BioSpace News Archive

Drug Development

/C O R R E C T I O N -- Shanghai Green Valley Pharmaceutical Co., Ltd/

In the news release, Innovative Alzheimer’s Treatment from China Concludes Phase 3 Clinical Trials, issued 19-Jul-2018 by Shanghai Green Valley Pharmaceutical Co., Ltd over PR Newswire

July 19, 2018
·
2 min read
Deals

Free Technical Briefing on Biotech Stocks -- ARCA biopharma, Achieve Life Sciences, Acorda Therapeutics, and Adaptimmune Therapeutics

On Wednesday, July 18, 2018, US markets saw six out of nine sectors finishing the day in green, two in red, and one in neutral territory. Benchmark US indices were mixed at the end of yesterday’s session - NASDAQ Composite was down 0.01%, closing at 7,854.44;

July 19, 2018
·
6 min read
Lilly’s Once-Weekly Trulicity® (dulaglutide) Label Updated to Include Data Showing Benefits for Adults with Type 2 Diabetes and Chronic Kidney Disease

The U.S. label for Eli Lilly and Company’s (NYSE: LLY) once-weekly Trulicity® (dulaglutide) is updated to show the medicine’s safety and efficacy in people with type 2 diabetes who have moderate to severe chronic kidney disease (CKD).

July 19, 2018
·
10 min read
Business

Teleflex Announces Second Quarter 2018 Earnings Conference Call Information

Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, August 2, 2018

July 19, 2018
·
1 min read
Business

Acorda Second Quarter Update: Webcast/Conference Call Scheduled for August 2, 2018

Acorda Therapeutics, Inc. will host a conference call and webcast to report its second quarter 2018 update and financial results on Thursday, August 2 at 8:30 a.m. ET.

July 19, 2018
·
3 min read
Pharm Country

WindRose Health Investors, LLC Announces Recapitalization of basys, LLC

WindRose Health Investors, LLC announced that funds managed by WindRose have completed a recapitalization of basys, LLC

July 19, 2018
·
3 min read
Policy

EpigenCare Files Patent for Epigenetic Testing Towards Personalized Consumer Skincare

EpigenCare Inc. announced the filing of its patent application, “A method of creating epigenetic skin profile associated with skin quality.”

July 19, 2018
·
2 min read
Business

GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug

GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center, University of Minnesota.

July 19, 2018
·
4 min read
Drug Development

Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration

Allergan plc, a leading global pharmaceutical company and Molecular Partners, a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced the release of two positive clinical trials.

July 19, 2018
·
10 min read
AHF Calls for International AIDS Conference (IAC) Participants and the World to “Keep the Promise” on HIV/AIDS

As Amsterdam prepares to welcome over 20,000 conference-goers, the largest global AIDS organization posts provocative advocacy ads throughout the city and at Schiphol Airport reminding people that there is still much to be done in the global fight against HIV/AIDS.

July 19, 2018
·
6 min read